検索条件

閉じる

検索結果 106 件

フルテキストURL ArchVirol_159_1_163.pdf
著者 Kondo, Hideki| Maeda, Takanori| I Wayan Gara| Chiba, Sotaro| Maruyama, Kazuyuki| Tamada, Tetsuo| Suzuki, Nobuhiro|
発行日 2013-07-16
出版物タイトル Archives of Virology
159巻
1号
出版者 Springer
開始ページ 163
終了ページ 166
ISSN 0304-8608
NCID AA00548901
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
論文のバージョン author
PubMed ID 23857506
DOI 10.1007/s00705-013-1784-6
Web of Science KeyUT 000330584800017
関連URL isVersionOf https://doi.org/10.1007/s00705-013-1784-6
フルテキストURL Arch_Virol_160_8_2099.pdf
著者 Kondo, Hideki| Takemoto, Shogo| Maruyama, Kazuyuki| Chiba, Sotaro| Ida Bagus Andika| Suzuki, Nobuhiro|
発行日 2015-05-31
出版物タイトル Archives of Virology
160巻
8号
出版者 Springer
開始ページ 2099
終了ページ 104
ISSN 0304-8608
NCID AA00548901
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
論文のバージョン author
PubMed ID 26025156
DOI 10.1007/s00705-015-2460-9
Web of Science KeyUT 000359434000026
関連URL isVersionOf https://doi.org/10.1007/s00705-015-2460-9
フルテキストURL VirusRes_177_1_75.pdf Table 1-revised.pdf FigS-revised.pdf Figs_revised.pdf Table S.pdf
著者 Kondo, Hideki| Hirano, Shuichi| Chiba, Sotaro| Andika, Ida Bagus| Hirai, Makoto| Maeda, Takanori| Tamada, Tetsuo|
キーワード AlkB Benyvirus Burdock mottle virus Endogenous viral element Paleovirology Transcriptome shotgun assembly
発行日 2013-10
出版物タイトル Virus Research
177巻
1号
出版者 Elsevier Science
開始ページ 75
終了ページ 86
ISSN 01681702
NCID AA10642076
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
論文のバージョン author
PubMed ID 23911632
DOI 10.1016/j.virusres.2013.07.015
Web of Science KeyUT 000324974100009
関連URL isVersionOf https://doi.org/10.1016/j.virusres.2013.07.015
フルテキストURL Virology_533_125.pdf
著者 Lin, Yu-Hsin| Fujita, Miki| Chiba, Sotaro| Hyodo, Kiwamu| Andika, Ida Bagus| Suzuki, Nobuhiro| Kondo, Hideki|
キーワード Ambisense Bipartite genome Endogenous virus element Evolution High-throughput sequencing Lentinula edodes Mymonaviridae Negative-strand RNA virus Phenuiviridae Shitake mushroom
備考 This fulltext will be available in May 2020|
発行日 2019-07-31
出版物タイトル Virology
533巻
出版者 Academic Press
開始ページ 125
終了ページ 136
ISSN 00426822
NCID AA00884454
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
論文のバージョン author
PubMed ID 31153047
DOI 10.1016/j.virol.2019.05.008
Web of Science KeyUT 000474941300015
関連URL isVersionOf https://doi.org/10.1016/j.virol.2019.05.008
フルテキストURL K0005907_abstract_review.pdf K0005907_summary.pdf K0005907_fulltext.pdf
著者 畑山 一貴|
発行日 2019-03-25
資料タイプ 学位論文
学位授与番号 甲第5907号
学位授与年月日 2019-03-25
学位・専攻分野 博士(医学)
授与大学 岡山大学
言語 英語
JaLCDOI 10.18926/AMO/56178
フルテキストURL 72_4_401.pdf
著者 Wada, Nozomu| Ikeda, Fusao| Mori, Chizuru| Takaguchi, Koichi| Fujioka, Shin-ichi| Kobashi, Haruhiko| Morimoto, Yoichi| Kariyama, Kazuya| Sakaguchi, Kosaku| Hashimoto, Noriaki| Moriya, Akio| Kawaguchi, Mitsuhiko| Miyatake, Hirokazu| Hagihara, Hiroaki| Kubota, Junichi| Takayama, Hiroki| Takeuchi, Yasuto| Yasunaka, Tetsuya| Takaki, Akinobu| Iwasaki, Yoshiaki| Okada, Hiroyuki|
抄録 Daclatasvir (DCV) + asunaprevir (ASV) combination therapy has become available for patients with hepatitis C virus (HCV) serogroup 1 infection. We studied the efficacy of this therapy by focusing on the factors associated with sustained virological responses (SVR) including resistance-associated variants (RAVs) and mixed infection of different HCV genotypes. We enrolled 951 HCV serogroup 1-positive patients who received this combination therapy at our hospital or affiliated hospitals. The presence of RAVs in non-structural (NS) regions 3 and 5A was analyzed by direct sequencing. HCV genotypes were determined by PCR with genotype-specific primers targeting HCV core and NS5B regions. SVR was achieved in 91.1% of patients. Female sex, age > 70 years, and RAVs were significantly associated with non-SVR (p<0.01 for all). Propensity score-matching results among the patients without RAVs regarding sex, age, and fibrosis revealed that mixed HCV infection determined by HCV NS5B genotyping showed significantly lower SVR rates than 1B-mono infection (p=0.02). Female sex and RAVs were significant factors associated with treatment failure of this combination therapy for patients with HCV serogroup 1 infection. Mixed HCV infection other than 1B-mono infection would be useful for predicting treatment failure.
キーワード mixed genotype daclatasvir asunaprevir HCV serogrouping 1 infection
Amo Type Original Article
出版物タイトル Acta Medica Okayama
発行日 2018-08
72巻
4号
出版者 Okayama University Medical School
開始ページ 401
終了ページ 406
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 CopyrightⒸ 2018 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 30140089
フルテキストURL viruses-09-00371.pdf
著者 Ogawa, Hirohito| Kajihara, Masahiro| Nao, Naganori| Shigeno, Asako| Fujikura, Daisuke| Hang’ombe, Bernard M.| Mweene, Aaron S.| Mutemwa, Alisheke| Squarre, David| Yamada, Masao| Higashi, Hideaki| Sawa, Hirofumi| Takada, Ayato|
キーワード Eidolon helvum Zambia adenovirus bat
発行日 2017-12-04
出版物タイトル Viruses
9巻
12号
出版者 MDPI
開始ページ 371
ISSN 1999-4915
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 https://creativecommons.org/licenses/by-nc-nd/4.0/deed.ja
論文のバージョン publisher
PubMed ID 29207524
DOI 10.3390/v9120371
関連URL isVersionOf https://doi.org/10.3390/v9120371
フルテキストURL K0005289_other1.pdf
著者 Takeda, Midori| Ikeda, Masanori| Ariumi, Yasuo| Wakita, Takaji| Kato, Nobuyuki|
備考 学位審査副論文|
発行日 2012-07
出版物タイトル Journal of General Virology
93巻
7号
出版者 Cambridge Univ. Press for the Society for General Microbiology
開始ページ 1422
終了ページ 1431
ISSN 0022-1317
NCID AA00698722
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 https://creativecommons.org/licenses/by-nc-nd/4.0/deed.ja
論文のバージョン author
PubMed ID 22456614
DOI 10.1099/vir.0.040725-0
Web of Science KeyUT 000306348900003
関連URL https://doi.org/10.1099/vir.0.040725-0 http://ousar.lib.okayama-u.ac.jp/54272
フルテキストURL K0005288_other.pdf
著者 Sejima, Hiroe| Mori, Kyoko| Ariumi, Yasuo| Ikeda, Masanori| Kato, Nobuyuki|
キーワード HCV HCV RNA replication system Li23 cells Long-term RNA replication Upregulated host genes Downregulated host genes
備考 学位審査副論文|
発行日 2012-07
出版物タイトル Virus Research
167巻
1号
出版者 Elsevier Science
開始ページ 74
終了ページ 85
ISSN 0168-1702
NCID AA10642076
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 https://creativecommons.org/licenses/by-nc-nd/4.0/deed.ja
論文のバージョン author
PubMed ID 22579597
DOI 10.1016/j.virusres.2012.04.008
Web of Science KeyUT 000305496700010
関連URL https://doi.org/10.1016/j.virusres.2012.04.008 http://ousar.lib.okayama-u.ac.jp/54271
フルテキストURL K0005477_abstract_review.pdf K0005477_summary.pdf K0005477_fulltext.pdf
著者 宮崎 裕樹|
発行日 2017-03-24
資料タイプ 学位論文
学位授与番号 甲第5477号
学位授与年月日 2017-03-24
学位・専攻分野 博士(医学)
授与大学 岡山大学
言語 英語
タイトル(別表記) The 2015 Incentive Award of the Okayama Medical Association in Cancer Research (2015 Hayashibara Prize and Yamada Prize)
フルテキストURL 128_99.pdf
著者 團迫 浩方|
出版物タイトル 岡山医学会雑誌
発行日 2016-08-01
128巻
2号
開始ページ 99
終了ページ 102
ISSN 0030-1558
関連URL https://doi.org/10.4044/joma.128.99
言語 日本語
著作権者 Copyright (c) 2016 岡山医学会
論文のバージョン publisher
DOI 10.4044/joma.128.99
NAID 130005262636
タイトル(別表記) The 2015 Incentive Award of the Okayama Medical Association in General Medical Science (2015 Yuuki Prize)
フルテキストURL 128_91.pdf
著者 梶田 藍|
出版物タイトル 岡山医学会雑誌
発行日 2016-08-01
128巻
2号
開始ページ 91
終了ページ 94
ISSN 0030-1558
関連URL isVersionOf https://doi.org/10.4044/joma.128.91
言語 日本語
著作権者 Copyright (c) 2016 岡山医学会
論文のバージョン publisher
DOI 10.4044/joma.128.91
NAID 130005262638
JaLCDOI 10.18926/AMO/54190
フルテキストURL 70_2_111.pdf
著者 Takeda, Midori| Ikeda, Masanori| Satoh, Shinya| Dansako, Hiromichi| Wakita, Takaji| Kato, Nobuyuki|
抄録 Membrane transport probably participates in the lifecycle of hepatitis C virus (HCV). Rab proteins are essential host factors for HCV RNA replication, but these proteins’ roles in other steps of the HCV lifecycle are not clear. The tight junction (TJ) plays a key role in HCV infection. Rab13 regulates the endocytic recycling of the TJ-associated proteins. Here we investigated whether Rab13 is involved in the HCV entry step. We used HuH-7-derived RSc cells and Li23-derived D7 cells. To evaluate the effect of Rab13 in HCV infection, we transfected the cells with siRNA targeting Rab13 before HCV infection. The down-regulation of Rab13 inhibited HCV infection. The D7 cells had showed a greater inhibitory effect against HCV infection compared to that in the RSc cells by Rab13 knockdown. Next, to evaluate the effect of Rab13 after infection, we inoculated the cells with HCV before transfection of the siRNA. The down-regulation of Rab13 did not show any effects after HCV infection. We further examined whether Rab13 would influence HCV RNA replication by using HCV replicon-harboring cells. The results revealed that Rab13 did not affect the step of HCV RNA replication. These results suggest that Rab13 plays an important role in the step of HCV entry.
キーワード hepatitis C virus Rab13 occludin claudin 1
Amo Type Original Article
出版物タイトル Acta Medica Okayama
発行日 2016-04
70巻
2号
出版者 Okayama University Medical School
開始ページ 111
終了ページ 118
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 CopyrightⒸ 2016 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 27094836
Web of Science KeyUT 000377626300006
JaLCDOI 10.18926/AMO/54186
フルテキストURL 70_2_75.pdf
著者 Sejima, Hiroe| Satoh, Shinya| Dansako, Hiromichi| Honda, Masao| Kaneko, Shuichi| Ikeda, Masanori| Kato, Nobuyuki|
抄録 The mechanisms of hepatitis C virus (HCV)-associated hepatocarcinogenesis and disease progression are unclear. We previously observed that the expression level of carboxypeptidase B2 (CPB2) gene was remarkably suppressed by persistent HCV RNA replication in human hepatoma cell line Li23-derived cells. The results of the present study demonstrated that the CPB2 expression in patients with chronic hepatitis C was inversely correlated with several risk factors of hepatic fibrosis or steatosis, although ectopic CPB2 expression did not suppress the expression of fibrogenic or lipogenic genes. The suppressed CPB2 expression was restored by treatment with 5-azacytidine. To clarify the mechanism underlying this phenomenon, we analyzed the CPB2 promoter, and the results revealed that (1) hepatocyte nuclear factor 1 (HNF1), especially HNF1α, was essential for the CPB2 promoter, and (2) CPB2 promoter was not methylated by persistent HCV RNA replication. The expression levels of HNF1α and HNF1β were also not changed by persistent HCV RNA replication. These results suggest the existence of 5-azacytidine-inducible or -reducible unknown factor(s) that can control the CPB2 expression. To evaluate this idea we performed a microarray analysis, and several gene candidates corresponding to the suggested factor(s) were identified.
キーワード persistent hepatitis C virus replication carboxypeptidase B2 suppression mechanism of CPB2 expression DNA methylation hepatocyte nuclear factor 1
Amo Type Original Article
出版物タイトル Acta Medica Okayama
発行日 2016-04
70巻
2号
出版者 Okayama University Medical School
開始ページ 75
終了ページ 88
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 CopyrightⒸ 2016 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 27094832
Web of Science KeyUT 000377626300002
著者 Kato, Nobuyuki| Sejima, Hiroe| Ueda, Youki| Mori, Kyoko| Satoh, Shinya| Dansako, Hiromichi| Ikeda, Masanori|
発行日 2014-03-13
出版物タイトル PLOS ONE
9巻
3号
資料タイプ 学術雑誌論文
著者 Ueda, Youki| Takeda, Midori| Mori, Kyoko| Dansako, Hiromichi| Wakita, Takaji| Kim, Hye-Sook| Sato, Akira| Wataya, Yusuke| Ikeda, Masanori| Kato, Nobuyuki|
発行日 2013-08-30
出版物タイトル PLOS ONE
8巻
8号
資料タイプ 学術雑誌論文
タイトル(別表記) The 56th Annual Meeting of the Japanese Society for Clinical Virology
フルテキストURL 127_261.pdf
著者 山田 雅夫|
出版物タイトル 岡山医学会雑誌
発行日 2015-12-01
127巻
3号
開始ページ 261
終了ページ 262
ISSN 0030-1558
関連URL isVersionOf https://doi.org/10.4044/joma.127.261
言語 日本語
著作権者 Copyright (c) 2015 岡山医学会
論文のバージョン publisher
DOI 10.4044/joma.127.261
NAID 130005116805
JaLCDOI 10.18926/AMO/53674
フルテキストURL 69_5_279.pdf
著者 Saito, Yukie| Fujii, Yousuke| Yashiro, Masato| Tsuge, Mitsuru| Nosaka, Nobuyuki| Yamashita, Nobuko| Yamada, Mutsuko| Tsukahara, Hirokazu| Morishima, Tsuneo|
抄録 Lung hyperpermeability affects the development of acute respiratory distress syndrome (ARDS), but therapeutic strategies for the control of microvascular permeability have not been established. We examined the effects of edaravone, dexamethasone, and N-monomethyl-L-arginine (L-NMMA) on permeability changes in human pulmonary microvascular endothelial cells (PMVEC) under a hypercytokinemic state. Human PMVEC were seeded in a Boyden chamber. After monolayer confluence was achieved, the culture media were replaced respectively by culture media containing edaravone, dexamethasone, and L-NMMA. After 24-h incubation, the monolayer was stimulated with tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β). Fluorescein-labeled dextran was added. Then the trans-human PMVEC leak was measured. Expressions of vascular endothelial-cadherin (VE-cadherin) and zonula occludens-1 protein (ZO-1) were evaluated using real-time quantitative polymerase chain reaction and immunofluorescence microscopy. The results showed that TNF-α+IL-1β markedly increased pulmonary microvascular permeability. Pretreatment with edaravone, dexamethasone, or L-NMMA attenuated the hyperpermeability and inhibited the cytokine-induced reduction of VE-cadherin expression on immunofluorescence staining. Edaravone and dexamethasone increased the expression of ZO-1 at both the mRNA and protein levels. Edaravone and dexamethasone inhibited the permeability changes of human PMVEC, at least partly through an enhancement of VE-cadherin. Collectively, these results suggest a potential therapeutic approach for intervention in patients with ARDS.
キーワード pulmonary microvascular endothelial cells permeability edaravone vascular endothelial-cadherin zonula occludens-1 protein
Amo Type Original Article
出版物タイトル Acta Medica Okayama
発行日 2015-10
69巻
5号
出版者 Okayama University Medical School
開始ページ 279
終了ページ 290
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 CopyrightⒸ 2015 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 26490025
Web of Science KeyUT 000365519600004
著者 Dansako, Hiromichi| Ueda, Youki| Okumura, Nobuaki| Satoh, Shinya| Sugiyama, Masaya| Mizokami, Masashi| Ikeda, Masanori| Kato, Nobuyuki|
発行日 2015
出版物タイトル The FEBS journal
資料タイプ 学術雑誌論文
JaLCDOI 10.18926/AMO/53560
フルテキストURL 69_4_237.pdf
著者 Nanba, Shintarou| Ikeda, Fusao| Fujioka, Shin-ichi| Araki, Yasuyuki| Takaguchi, Kouichi| Hashimoto, Noriaki| Seki, Hiroyuki| Takaki, Akinobu| Iwasaki, Yoshiaki| Yamamoto, Kazuhide|
抄録 The effectiveness of extending treatment duration as response guided therapy was previously reported for chronic hepatitis C (CHC) genotype 1, but is still controversial for genotype 2. The present study is a retrospective cohort study to investigate the effectiveness of extending treatment duration in therapy with pegylated interferon and ribavirin for patients with CHC genotype 2 by focusing on the timing at which patients obtained undetectable HCV RNA. A total of 306 patients who obtained undetectable HCV RNA by week 24 of treatment and completed 24 weeks of treatment were enrolled. Rapid virological response (RVR) to standard therapy was achieved by 122 patients (51オ), and 89オ of them obtained sustained virological response (SVR), while 69オ of non-RVR patients achieved SVR. Non-RVR patients with undetectable HCV RNA at week 8, and insufficient adherence<80オ pegylated interferon and ribavirin during the first 24 weeks, significantly improved their SVR rate by extended therapy. Among patients receiving extended therapy, drug adherences did not differ between SVR and non-SVR patients, indicating that extending treatment duration might compensate for insufficient antiviral effects due to insufficient drug adherences. This finding might be useful in creating a guideline for extending treatment duration for patients with CHC genotype 2.
キーワード hepatitis C virus interferon genotype 2 response-guided therapy
Amo Type Original Article
出版物タイトル Acta Medica Okayama
発行日 2015-08
69巻
4号
出版者 Okayama University Medical School
開始ページ 237
終了ページ 244
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 CopyrightⒸ 2015 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 26289915
Web of Science KeyUT 000365519100007